Pediatric AML: Clinical Trials

2 trials for Pediatric AML, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1
Phase 21Unknown 1

Follow Pediatric AML: new trials by email Literature Review of Pediatric AML trials Research Report on Pediatric AML

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
Cladribine, G-CSF, Cytarabine - Leukemia, Monocytic, Acute, Pediatric AML
Phase 2 / Phase 3UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University432021-12-012023-07-27
Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia
ARM A: Active Comparator Drug, ARM B: Blocks Therapy Drug - AML, Pediatric AML
Phase 3CompletedGrupo Argentino de Tratamiento de la Leucemia Aguda2582007-08-012024-01-18

Narrower conditions

Leukemia, Monocytic, Acute (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Cladribine (1)  ·  Cytarabine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Idarubicin (1)  ·  Mitoxantrone (1)  ·  Sorafenib (1)

Sponsors

Grupo Argentino de Tratamiento de la Leucemia Aguda (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)

Countries

China (1)

Top investigators

Alcyra Fynn, Dr. (1)

Results publications

PMID 19242495, PMID 31279288, PMID 40367210